Subject
Pharmacology,Internal Medicine
Reference85 articles.
1. EMA. New add-on treatment to insulin for treatment of certain patients with type 1 diabetes. Available from: https://www.ema.europa.eu/en/news/new-add-treatment-insulin-treatment-certain-patients-type-1-diabetes. Accessed October 25, 2023.
2. EMA. First oral add-on treatment to insulin for the treatment of certain patients with type 1 diabetes. Available from: https://www.ema.europa.eu/en/documents/press-release/first-oral-add-treatment-insulin-treatment-certain-patients-type-1-diabetes_. Accessed October 25, 2023.
3. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
4. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
5. Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献